Quantcast

Latest Mesenchymal stem cell Stories

2012-11-07 11:43:11

Data reported in late breaker presentation at the American Heart Association Annual Meeting and simultaneously published in the Journal of the American Medical Association BioCardia, Inc., focused on regenerative biologic therapies for cardiovascular disease, today announced positive results from a Phase 1/2 heart failure trial using the Company's Helical Infusion System, comprising the Helical Infusion System Catheter and Morph® Vascular Access Catheter, to deliver allogeneic, or...

2012-10-13 04:03:22

Stem cell transfusions may someday replace the need for transplants in patients who suffer from liver failure caused by hepatitis B, according to a new study coming out of Beijing. . The results are published in the October issue of STEM CELLS Translational Medicine. Worldwide more than 500,000 people die each year from this condition. Durham, NC (PRWEB) October 11, 2012 Stem cell transfusions may someday replace the need for transplants in patients who suffer from liver failure caused by...

2012-09-08 23:01:31

A new pre-clinical study demonstrates how stem cells may significantly reduce the ripple-effect damage caused by a heart attack. The study, by researchers at the University of Maryland School of Medicine in Baltimore, appears in the September issue of STEM CELLS Translational Medicine. Durham, NC (PRWEB) September 07, 2012 A new pre-clinical study demonstrates how stem cells may significantly reduce the ripple-effect damage caused by a heart attack. The study, by researchers at the...

2012-08-15 23:00:07

Stemedica International, SA (Epalinges, Switzerland), a wholly owned subsidiary of Stemedica Cell Technologies, Inc. (“Stemedica”), a leader in adult stem cell research and manufacturing, announced today that it has been granted a series of licenses by Swissmedic (the Swiss equivalent of the United States Food and Drug Administration). These licenses specifically authorize the Company to import and export its Stemedyne stem cell products worldwide for human use in approved...

2012-08-13 13:01:54

Duke researchers may have found a promising stem cell therapy for preventing osteoarthritis after a joint injury. Injuring a joint greatly raises the odds of getting a form of osteoarthritis called post-traumatic arthritis, or PTA. There are no therapies yet that modify or slow the progression of arthritis after injury. Researchers at Duke University Health System have found a very promising therapeutic approach to PTA using a type of stem cell, called mesenchymal stem cells (MSCs), in...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related